1-(Thiazol-2-yl)piperazine → N-(1-(4-((4-(thiazol-2-yl)piperazin-1-yl)methyl)phenyl)ethyl)acetamide
Reaction equation
Cl[CH2:2][C:3]1[CH:8]=[CH:7][C:6]([CH:9]([NH:11][C:12](=[O:14])[CH3:13])[CH3:10])=[CH:5][CH:4]=1.[S:15]1[CH:19]=[CH:18][N:17]=[C:16]1[N:20]1[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]1>>[S:15]1[CH:19]=[CH:18][N:17]=[C:16]1[N:20]1[CH2:21][CH2:22][N:23]([CH2:2][C:3]2[CH:8]=[CH:7][C:6]([CH:9]([NH:11][C:12](=[O:14])[CH3:13])[CH3:10])=[CH:5][CH:4]=2)[CH2:24][CH2:25]1Participants
3
Procedure
By similar reaction and treatment to that in Example 1(5) using N-(1-(4-chloromethylphenyl)ethyl)acetamide obtained in Example 48(3) instead of N-(4-chloromethylphenylmethyl)acetamide and 1-(thiazol-2-yl)piperazine obtained in Example 81(1) instead of phenylpiperazine, the title compound was obtained as white crystals, m.p.=136-137° C.
Workup
- customBy similar reaction and treatment to that in Example
Sources & evidence
- ORD record
- ord-6f7a131e936a49dbb0d8d3a2c626014e
- Source dataset
- uspto-grants-2002_09
- Patent number
- US06455528B1
Reaction notes
Loading…